--- title: "DSMB, Data Safety Monitoring Board | MedTech Terms" description: "Independent committee that periodically reviews accumulating safety and (sometimes) efficacy data during a trial." lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/dsmb#term", "name": "Data Safety Monitoring Board", "alternateName": "DSMB", "description": "DSMBs (also DMC) make recommendations to continue, modify, or stop a trial based on safety, futility, or overwhelming benefit. Their charter, membership, and stopping rules are pre-specified.", "url": "https://medtechterms.com/terms/dsmb", "termCode": "dsmb", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/dsmb#article", "headline": "DSMB, Data Safety Monitoring Board", "description": "Independent committee that periodically reviews accumulating safety and (sometimes) efficacy data during a trial.", "url": "https://medtechterms.com/terms/dsmb", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/dsmb" }, "about": { "@id": "https://medtechterms.com/terms/dsmb#term" }, "articleSection": "Clinical & Trials", "inLanguage": "en", "keywords": "Data Safety Monitoring Board, DSMB, Clinical & Trials, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "FDA DMC Guidance", "url": "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/establishment-and-operation-clinical-trial-data-monitoring-committees", "publisher": { "@type": "Organization", "name": "FDA" } }, { "@type": "CreativeWork", "name": "ClinicalTrials.gov", "url": "https://clinicaltrials.gov/", "publisher": { "@type": "Organization", "name": "NIH" } }, { "@type": "CreativeWork", "name": "ICH Guidelines", "url": "https://www.ich.org/page/ich-guidelines", "publisher": { "@type": "Organization", "name": "ICH" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/pivotal-trial#term", "name": "Pivotal Trial", "url": "https://medtechterms.com/terms/pivotal-trial" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/adaptive-trial#term", "name": "Adaptive Trial Design", "url": "https://medtechterms.com/terms/adaptive-trial" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Clinical & Trials", "item": "https://medtechterms.com/terms?cat=Clinical%20%26%20Trials" }, { "@type": "ListItem", "position": 4, "name": "Data Safety Monitoring Board", "item": "https://medtechterms.com/terms/dsmb" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/dsmb#faq", "mainEntity": [ { "@type": "Question", "name": "What is the primary role of a DSMB?", "acceptedAnswer": { "@type": "Answer", "text": "A DSMB's primary role is to protect the safety of trial participants and to ensure the ethical conduct and scientific integrity of a clinical trial by periodically reviewing unblinded accumulating data." } }, { "@type": "Question", "name": "When is a DSMB typically required?", "acceptedAnswer": { "@type": "Answer", "text": "DSMBs are typically required for large, complex, or high-risk clinical trials, especially those involving serious or life-threatening conditions, vulnerable populations, or trials that involve interim analyses for efficacy or futility." } }, { "@type": "Question", "name": "Who comprises a DSMB?", "acceptedAnswer": { "@type": "Answer", "text": "A DSMB is composed of independent experts, often including clinicians, biostatisticians, ethicists, and other specialists relevant to the therapeutic area, who are free from conflicts of interest." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Clinical & Trials](/terms?cat=Clinical%20%26%20Trials) 6. / 7. Data Safety Monitoring Board [All terms](/terms) Clinical & Trials [Clinical Evidence](/ecosystems/clinical-evidence)[Startup Lifecycle](/ecosystems/startup-lifecycle)DSMB # Data Safety Monitoring Board Independent committee that periodically reviews accumulating safety and (sometimes) efficacy data during a trial. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition DSMBs (also DMC) make recommendations to continue, modify, or stop a trial based on safety, futility, or overwhelming benefit. Their charter, membership, and stopping rules are pre-specified. What the regulation says The FDA guidance "Establishment and Operation of Clinical Trial Data Monitoring Committees" outlines expectations for DSMBs, particularly for trials with vulnerable populations, high-risk interventions, or those with early stopping points. Similarly, ICH E6(R2) [Good Clinical Practice](/terms/gcp) guidelines emphasize the importance of independent data monitoring for ensuring subject safety and data integrity during clinical trials. ## What this means in practice Required or strongly recommended for pivotal trials with mortality endpoints, vulnerable populations, or interim analyses. ## Examples - A Class III medical device clinical trial for a novel implantable cardiac device establishes a DSMB to monitor for adverse events, given the device's invasive nature and potential impact on patient mortality. - A pharmaceutical company conducting a Phase III trial for a new oncology drug forms a DSMB to evaluate interim efficacy and safety data, as the study involves a vulnerable patient population and has pre-specified interim analysis points. - A clinical investigator working on an NIH-funded study for a rare pediatric disease is required to convene a DSMB due to the involvement of a vulnerable population and the potential for serious outcomes. Common pitfalls - • Failing to clearly define the DSMB's charter, including its roles, responsibilities, and reporting structure, can lead to operational inefficiencies. - • Not ensuring the independence of DSMB members from the trial sponsor and investigators can compromise objectivity and regulatory acceptance. - • Inadequate definition of stopping rules or interim analysis plans can create ambiguity and delay critical decisions. - • Ignoring DSMB recommendations without proper justification can result in regulatory non-compliance and ethical concerns. - • Lack of documented communication channels and procedures between the DSMB, sponsor, and regulatory authorities can lead to misunderstandings and delays. ## Frequently asked questions What is the primary role of a DSMB? A DSMB's primary role is to protect the safety of trial participants and to ensure the ethical conduct and scientific integrity of a clinical trial by periodically reviewing unblinded accumulating data. When is a DSMB typically required? Who comprises a DSMB? ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Clinical & Trials Adaptive Trial Design Trial design that pre-specifies opportunities to modify aspects (sample size, arms, endpoints) based on interim data. ](/terms/adaptive-trial)[ Clinical & Trials Pivotal Trial Definitive clinical study designed to establish safety and effectiveness for marketing authorization. ](/terms/pivotal-trial) ### More in Clinical & Trials · Same category [ Clinical & Trials Adverse Event(AE) Any untoward medical occurrence in a subject, whether or not related to the device. ](/terms/adverse-event)[ Clinical & Trials ALCOA+ Data integrity principles: Attributable, Legible, Contemporaneous, Original, Accurate (plus Complete, Consistent, Enduring, Available). ](/terms/alcoa-plus)[ Clinical & Trials Analytical Sensitivity An IVD's ability to detect small quantities of an analyte. ](/terms/analytical-sensitivity)[ Clinical & Trials Bayesian Trial Design Trial design that uses Bayesian statistics, often incorporating prior data from related studies or registries. ](/terms/bayesian-trial) Cited by Where this term appears across MedTech Terms. Ecosystems (2) - [Clinical Evidence](/ecosystems/clinical-evidence) - [Startup Lifecycle](/ecosystems/startup-lifecycle) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 FDA· 1 NIH· 1 ICH· 1 1. [1 FDA DMC Guidance Verified FDA · fda.gov ](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/establishment-and-operation-clinical-trial-data-monitoring-committees) 2. [2 ClinicalTrials.gov Verified NIH · clinicaltrials.gov ](https://clinicaltrials.gov/) 3. [3 ICH Guidelines Verified ICH · ich.org ](https://www.ich.org/page/ich-guidelines) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Clinical evidence intersecting with device security? We support clinical-stage MedTech teams whose investigational devices touch patient data or hospital networks. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Clinical & Trials Acronym DSMB Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=dsmb) Learn in 60 seconds Card Lesson Quiz Independent committee that periodically reviews accumulating safety and (sometimes) efficacy data during a trial. - · Required or strongly recommended for pivotal trials with mortality endpoints, vulnerable populations, or interim analyses. - · Their charter, membership, and stopping rules are pre-specified. Remember this Watch out: Failing to clearly define the DSMB's charter, including its roles, responsibilities, and reporting structure, can lead to operational inefficiencies. Related terms - [Pivotal Trial ](/terms/pivotal-trial) - [Adaptive Trial Design ](/terms/adaptive-trial) You may also need Auto-suggested from Clinical & Trials and shared keywords. - [Feasibility Study ](/terms/feasibility-study) - [Institutional Review Board(IRB) ](/terms/irb) - [Primary and Secondary Endpoints ](/terms/primary-secondary-endpoint) - [Risk-Based Monitoring(RBM) ](/terms/risk-based-monitoring) - [Contract Research Organization(CRO) ](/terms/cro) - [Electronic Data Capture(EDC) ](/terms/edc) [All Clinical & Trials terms](/terms?cat=Clinical%20%26%20Trials) From the Blue Goat network Related resources and services on this topic. - [ MedTech Launchpad MedTech funding rounds, accelerators, and launch resources. ](https://medtechlaunchguide.com) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)